FARMAKON AS
Operating
Selge tjenester og varer innen Life science og annet som naturlig
sammenfaller med dette, samt deltakelse i andre selskaper,
investeringer og nærliggende virksomhet.
Organization
- CEO
- OC
- Chairman of the board
- OC
- Years since formation
- 4 years
- since Dec 14, 2022
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- company
- Belongs to group of
Financials
- Total operating income 2025
- 1,843,756
- NOK
- Annual total result 2025
- 219,505
- NOK
- Total equity 2025
- 571,081
- NOK
Last update: Apr 16, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
OC | Managing Director/CEO | 100 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
OC | Chairman | 100 % indirectly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
OC | Managing Director/CEO, Chairman | 100 % indirectly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 30,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -7,845Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 1,843,756 | 3,150,941 | 2,177,139 | 0 |
Annual Total Result | 219,505 | 929,896 | 702,818 | 0 |
Total assets | 1,049,966 | 1,897,051 | 1,386,476 | 24,430 |
Total liabilities | 478,885 | 1,345,475 | 1,164,798 | 0 |
Total equity | 571,081 | 551,576 | 221,678 | 24,430 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 1,843,756 | 3,150,941 | 2,177,139 | 0 |
Total operating costs | 1,556,607 | 2,211,476 | 1,267,747 | 0 |
Operating result | 287,149 | 939,465 | 909,392 | 0 |
Financial income/costs | -707 | -10,794 | -3,944 | 0 |
Profit before tax | 286,442 | 928,671 | 905,448 | 0 |
Total tax & extraordinary income/cost | 66,937 | -1,225 | 202,630 | 0 |
Annual Total Result | 219,505 | 929,896 | 702,818 | 0 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 36,416 | 60,693 | 0 | 0 |
Total current assets | 1,013,550 | 1,836,358 | 1,386,476 | 24,430 |
Total assets | 1,049,966 | 1,897,051 | 1,386,476 | 24,430 |
Short term debt | 451,725 | 1,318,475 | 1,137,798 | 0 |
Long term debt | 27,160 | 27,000 | 27,000 | 0 |
Total liabilities | 478,885 | 1,345,475 | 1,164,798 | 0 |
Contributed capital | 30,000 | 30,000 | 30,000 | 24,430 |
Retained earnings | 541,081 | 521,576 | 191,678 | 0 |
Total equity | 571,081 | 551,576 | 221,678 | 24,430 |
Total equity and liabilities | 1,049,966 | 1,897,051 | 1,386,476 | 24,430 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises